ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY (GBM) - ANVISA Registration 80003610582
Access comprehensive regulatory information for ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY (GBM) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80003610582 and manufactured by INOVA DIAGNOSTICS, INC.. The registration is held by WERFEN MEDICAL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, DR. FOOKE LABORATORIEN GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80003610582
25351477045202071
02004662000165
Company Information
Dates and Status
Aug 31, 2020
VIGENTE
09/18/2025 19:00:01
ANTICORPO ANTIMEMBRANA BASAL GLOMERULAR (GMB)
FAMILIA IFLASH- GBM IGG E GBM IGG CONTROL
SHENZHEN YHLO BIOTECH CO., LTD.
80867150107
Jul 15, 2021
ANTICORPO ANTIMEMBRANA BASAL GLOMERULAR (GMB)
EliA GBM Well
PHADIA AB
80254180386
May 06, 2021
ANTICORPO ANTIMEMBRANA BASAL GLOMERULAR (GMB)
AI-LFA GBM
DR. FOOKE LABORATORIEN GMBH
10300390827
Jul 08, 2019
ANTICORPO ANTIMEMBRANA BASAL GLOMERULAR (GMB)
Anti-GBM
ORGENTEC DIAGNOSTIKA GMBH
10300390672
May 20, 2019
ANTICORPO ANTIMEMBRANA BASAL GLOMERULAR (GMB)
Anti-GBM
ORGENTEC DIAGNOSTIKA GMBH
10300390712
May 20, 2019

